Khalid Awad Al-Kubaisi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Khalid Awad Al-Kubaisi has a total of 148 co-authors. Here are the top co-authors by number of shared publications:
- Nadia Al Mazrouei
College of Pharmacy, Department of Pharmacy Practice and Pharmacotherapeutics, University of Sharjah, Sharjah, United Arab Emirates
15 shared publications - Asim Ahmed Elnour
Program of Clinical Pharmacy, College of Pharmacy, Al Ain University, Abu Dhabi Campus
13 shared publications - Derar H. Abdel-Qader
Faculty of Pharmacy and Medical Sciences, University of Petra, Amman, Jordan
7 shared publications - Rana Ibrahim
Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates
6 shared publications - Semira Abdi Beshir
Department of Pharmacy Practice, College of Pharmacy, Dubai Medical University, Dubai, United Arab Emirates
6 shared publications - Abduelmula Rajab Abduelkarem
Department of Pharmacy Practice and Pharmacotherapy, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates
5 shared publications
Latest Publications
- Open Access
- 14 November 2026
- Published by F1000 Research Ltd in F1000Research
- Vol. 15, 1912
Gut Dysbiosis at the Intersection of Depression and Addiction: A Microbiota–Gut–Brain–Reward Framework and Digital Precision Behavioural Health Agenda for the United Arab Emirates
Background The microbiota–gut–brain axis provides an emerging framework for understanding neuropsychiatric disorders. Depression and addiction, despite substantial comorbidity, are frequently investigated separately. This review examines whether gut dysbiosis contributes to vulnerability, symptom persistence and recovery through shared inflammatory, endocrine, metabolic and reward-related mechanisms. Methods A structured narrative review was conducted using PubMed/MEDLINE, Scopus, Web of Science and PsycINFO, supplemented by citation searching. Priority was given to systematic reviews, meta-analyses, human cohorts, randomised trials and mechanistic studies. Evidence was evaluated for methodological quality, confounding, replication, biological plausibility and clinical relevance. Results Convergent evidence implicates altered short-chain fatty acid production, intestinal barrier dysfunction, dysregulated tryptophan–kynurenine metabolism, systemic inflammation, hypothalamic–pituitary–adrenal-axis disturbance and altered affective and reward signalling. Human evidence is strongest for major depressive disorder and alcohol use disorder, whereas evidence involving opioids, psychostimulants, cannabis and polysubstance use remains comparatively limited. Dietary interventions, probiotics, prebiotics, synbiotics and faecal microbiota transplantation demonstrate preliminary therapeutic potential. However, methodological heterogeneity, uncertain causality, limited replication and insufficient evidence of sustained benefit prevent routine clinical recommendation. Digital phenotyping, wearable technologies and artificial intelligence may facilitate integration of microbial, metabolic, behavioural and longitudinal clinical information, although prospective validation and demonstrated clinical utility remain limited. Conclusions The proposed Microbiota–Gut–Brain–Reward framework conceptualises dysbiosis as a potentially modifiable contributor rather than an independent cause of depression or addiction. Clinical translation requires longitudinal multi-omic research, harmonised methodologies, mechanistically informed trials and integration with established pharmacological, psychological and social interventions. Digitally enabled precision approaches may support personalised recovery monitoring, provided interpretability, privacy, equity and clinical governance are prioritised. The United Arab Emirates offers opportunities for culturally responsive translational research, although implementation must remain evidence-driven, ethically governed and subject to rigorous prospective evaluation before clinical adoption.
- 14 November 2026
- Published by F1000 Research Ltd in F1000Research
- Vol. 15, 1912
Open AccessGut Dysbiosis at the Intersection of Depression and Addiction: A Microbiota–Gut–Brain–Reward Framework and Digital Precision Behavioural Health Agenda for the United Arab Emirates
Background The microbiota–gut–brain axis provides an emerging framework for understanding neuropsychiatric disorders. Depression and addiction, despite substantial comorbidity, are frequently investigated separately. This review examines whether gut dysbiosis contributes to vulnerability, symptom persistence and recovery through shared inflammatory, endocrine, metabolic and reward-related mechanisms. Methods A structured narrative review was conducted using PubMed/MEDLINE, Scopus, Web of Science and PsycINFO, supplemented by citation searching. Priority was given to systematic reviews, meta-analyses, human cohorts, randomised trials and mechanistic studies. Evidence was evaluated for methodological quality, confounding, replication, biological plausibility and clinical relevance. Results Convergent evidence implicates altered short-chain fatty acid production, intestinal barrier dysfunction, dysregulated tryptophan–kynurenine metabolism, systemic inflammation, hypothalamic–pituitary–adrenal-axis disturbance and altered affective and reward signalling. Human evidence is strongest for major depressive disorder and alcohol use disorder, whereas evidence involving opioids, psychostimulants, cannabis and polysubstance use remains comparatively limited. Dietary interventions, probiotics, prebiotics, synbiotics and faecal microbiota transplantation demonstrate preliminary therapeutic potential. However, methodological heterogeneity, uncertain causality, limited replication and insufficient evidence of sustained benefit prevent routine clinical recommendation. Digital phenotyping, wearable technologies and artificial intelligence may facilitate integration of microbial, metabolic, behavioural and longitudinal clinical information, although prospective validation and demonstrated clinical utility remain limited. Conclusions The proposed Microbiota–Gut–Brain–Reward framework conceptualises dysbiosis as a potentially modifiable contributor rather than an independent cause of depression or addiction. Clinical translation requires longitudinal multi-omic research, harmonised methodologies, mechanistically informed trials and integration with established pharmacological, psychological and social interventions. Digitally enabled precision approaches may support personalised recovery monitoring, provided interpretability, privacy, equity and clinical governance are prioritised. The United Arab Emirates offers opportunities for culturally responsive translational research, although implementation must remain evidence-driven, ethically governed and subject to rigorous prospective evaluation before clinical adoption.
- Open Access
- 11 November 2026
- Published by Springer Nature in BMC Digital Health
- Vol. 4 (1) , 83
The impact of a culturally tailored telehealth education programme on glucose management and self-care behaviours in Jordanian adults living with type 2 diabetes: a randomised controlled trial
- 11 November 2026
- Published by Springer Nature in BMC Digital Health
- Vol. 4 (1) , 83
Open AccessThe impact of a culturally tailored telehealth education programme on glucose management and self-care behaviours in Jordanian adults living with type 2 diabetes: a randomised controlled trial
- Open Access
- 3 November 2026
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 19 (1)
Effects of pharmacists’ involvement in pharmacogenomics implementation on patient outcomes: a scoping review
- 3 November 2026
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 19 (1)
Open AccessEffects of pharmacists’ involvement in pharmacogenomics implementation on patient outcomes: a scoping review
- 27 June 2026
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 82 (7) , 190
The efficacy of letrozole in the medical management of ectopic pregnancy: a systematic review and meta-analysis
Objective This review aimed to assess the efficacy and safety of letrozole, administered either as monotherapy or combined with methotrexate, for the treatment of ectopic pregnancy (EP). Methods Following established guidelines (PRISMA), a systematic review and meta-analysis was conducted. Major online research databases (Web of Science, PubMed, Scopus, and Cochrane Library) were searched for studies comparing letrozole to methotrexate in women diagnosed with EP via ultrasound, from the earliest available records up to November 5, 2024. The combined results were analyzed using risk ratios (RR) and mean differences (MD) with 95% confidence intervals (CI). The quality of the included studies was evaluated using ROB-2 and ROBINS-I tools. Results Eight studies (five randomized and three non-randomized trials) involving 548 participants were included. Letrozole monotherapy achieved a higher treatment success rate compared to methotrexate (6 studies, 376 patients, RR 1.10, 95% CI [1.01, 1.20], p = 0.03). Combining letrozole with methotrexate showed comparable success rates to methotrexate alone (2 studies, 161 patients, RR 1.09, 95% CI [0.96, 1.23], p = 0.17). On day 4, β-human chorionic gonadotropin (β-hCG) levels decreased faster in both the letrozole monotherapy (5 studies, 291 patients, MD -131.15 mIU/mL, 95% CI [-220.77, -41.52], p = 0.004) and combination groups (2 studies, 136 patients, MD -188.79 mIU/mL, 95% CI [-242.07, -135.52], p < 0.00001). Letrozole monotherapy resulted in a smaller reduction in platelet count (2 studies, 76 patients, MD 81.61 × 10³/µL, 95% CI [40.11, 123.10], p = 0.0001) and better-preserved liver enzymes, such as ALT (3 studies, 76 patients, MD -21.27 IU/L, 95% CI [-24.42, -18.12], p < 0.00001). No differences were noted in anti-Müllerian hormone (AMH) levels (2 studies, 39 patients, MD -0.01 ng/mL, 95% CI [-0.40, 0.38], p = 0.97). Conclusions Letrozole, especially when used as the only treatment, may be a more effective and potentially safer alternative to methotrexate for medically treating EP. However, larger, higher-quality research studies are necessary to confirm these findings and to determine the best way to use letrozole.
- 27 June 2026
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 82 (7) , 190
The efficacy of letrozole in the medical management of ectopic pregnancy: a systematic review and meta-analysis
Objective This review aimed to assess the efficacy and safety of letrozole, administered either as monotherapy or combined with methotrexate, for the treatment of ectopic pregnancy (EP). Methods Following established guidelines (PRISMA), a systematic review and meta-analysis was conducted. Major online research databases (Web of Science, PubMed, Scopus, and Cochrane Library) were searched for studies comparing letrozole to methotrexate in women diagnosed with EP via ultrasound, from the earliest available records up to November 5, 2024. The combined results were analyzed using risk ratios (RR) and mean differences (MD) with 95% confidence intervals (CI). The quality of the included studies was evaluated using ROB-2 and ROBINS-I tools. Results Eight studies (five randomized and three non-randomized trials) involving 548 participants were included. Letrozole monotherapy achieved a higher treatment success rate compared to methotrexate (6 studies, 376 patients, RR 1.10, 95% CI [1.01, 1.20], p = 0.03). Combining letrozole with methotrexate showed comparable success rates to methotrexate alone (2 studies, 161 patients, RR 1.09, 95% CI [0.96, 1.23], p = 0.17). On day 4, β-human chorionic gonadotropin (β-hCG) levels decreased faster in both the letrozole monotherapy (5 studies, 291 patients, MD -131.15 mIU/mL, 95% CI [-220.77, -41.52], p = 0.004) and combination groups (2 studies, 136 patients, MD -188.79 mIU/mL, 95% CI [-242.07, -135.52], p < 0.00001). Letrozole monotherapy resulted in a smaller reduction in platelet count (2 studies, 76 patients, MD 81.61 × 10³/µL, 95% CI [40.11, 123.10], p = 0.0001) and better-preserved liver enzymes, such as ALT (3 studies, 76 patients, MD -21.27 IU/L, 95% CI [-24.42, -18.12], p < 0.00001). No differences were noted in anti-Müllerian hormone (AMH) levels (2 studies, 39 patients, MD -0.01 ng/mL, 95% CI [-0.40, 0.38], p = 0.97). Conclusions Letrozole, especially when used as the only treatment, may be a more effective and potentially safer alternative to methotrexate for medically treating EP. However, larger, higher-quality research studies are necessary to confirm these findings and to determine the best way to use letrozole.
- Open Access
- 19 May 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (5) , e0349439
Pharmacogenomics knowledge and implementation readiness among community pharmacists in Jordan: A national cross-sectional study
Pharmacogenomics (PGx) offers a powerful strategy to improve medication safety and efficacy, yet its integration into community pharmacy practice remains limited. While an “attitude-knowledge gap” is known to exist globally, limited national data exist concerning PGx readiness among community pharmacists in Jordan. This study aimed to (i) quantify Clinical Pharmacogenetics Implementation Consortium (CPIC)-aligned PGx knowledge and characterize attitudes; (ii) assess implementation readiness across organizational, leadership, and structural dimensions; (iii) map perceived barriers; and (iv) identify independent predictors of knowledge, attitudes, and readiness. A national, cross-sectional survey was conducted using a proportionate stratified random sampling method. A content-validated and reliability-tested electronic questionnaire was distributed to community pharmacists across Jordan’s three administrative regions. The instrument assessed demographics, CPIC-aligned knowledge, attitudes and perceived barriers on five-point Likert scales, and theory-informed implementation readiness. Data were analyzed using descriptive statistics, bivariate tests, and multiple linear regression. A total of 347 community pharmacists completed the survey. A vast majority (83.0%) reported no prior formal PGx training. Knowledge of practical PGx was low, with a mean score of 5.54 ± 2.12 out of 10. Attitudes were neutral (mean = 3.49 ± 0.26), while perceived barriers were rated as significant (mean severity = 3.45 ± 0.30), with privacy concerns being the highest-rated challenge (mean = 3.65 ± 0.78). Total implementation readiness was moderate (mean = 3.34 ± 0.25), with organizational readiness (mean = 3.39) rated higher than structural readiness (mean = 3.21) or leadership support (mean = 3.27). Bivariate analyses revealed few significant associations, and crucially, multiple linear regression models showed that no demographic or practice characteristics within the variables tested were significant independent predictors of knowledge or readiness. Jordanian community pharmacists demonstrated a significant gap between their positive attitudes towards PGx and the practical knowledge and systemic support required for clinical implementation. The findings revealed that the identified deficits in knowledge and readiness were widespread across all surveyed subgroups, not concentrated in specific demographic or professional subgroups. Translating the existing positive sentiment into routine clinical practice urgently requires a nationwide, standardized educational strategy coupled with the development of systemic enablers, including reimbursement pathways, integrated clinical workflows, and explicit leadership support.
- 19 May 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (5) , e0349439
Open AccessPharmacogenomics knowledge and implementation readiness among community pharmacists in Jordan: A national cross-sectional study
Pharmacogenomics (PGx) offers a powerful strategy to improve medication safety and efficacy, yet its integration into community pharmacy practice remains limited. While an “attitude-knowledge gap” is known to exist globally, limited national data exist concerning PGx readiness among community pharmacists in Jordan. This study aimed to (i) quantify Clinical Pharmacogenetics Implementation Consortium (CPIC)-aligned PGx knowledge and characterize attitudes; (ii) assess implementation readiness across organizational, leadership, and structural dimensions; (iii) map perceived barriers; and (iv) identify independent predictors of knowledge, attitudes, and readiness. A national, cross-sectional survey was conducted using a proportionate stratified random sampling method. A content-validated and reliability-tested electronic questionnaire was distributed to community pharmacists across Jordan’s three administrative regions. The instrument assessed demographics, CPIC-aligned knowledge, attitudes and perceived barriers on five-point Likert scales, and theory-informed implementation readiness. Data were analyzed using descriptive statistics, bivariate tests, and multiple linear regression. A total of 347 community pharmacists completed the survey. A vast majority (83.0%) reported no prior formal PGx training. Knowledge of practical PGx was low, with a mean score of 5.54 ± 2.12 out of 10. Attitudes were neutral (mean = 3.49 ± 0.26), while perceived barriers were rated as significant (mean severity = 3.45 ± 0.30), with privacy concerns being the highest-rated challenge (mean = 3.65 ± 0.78). Total implementation readiness was moderate (mean = 3.34 ± 0.25), with organizational readiness (mean = 3.39) rated higher than structural readiness (mean = 3.21) or leadership support (mean = 3.27). Bivariate analyses revealed few significant associations, and crucially, multiple linear regression models showed that no demographic or practice characteristics within the variables tested were significant independent predictors of knowledge or readiness. Jordanian community pharmacists demonstrated a significant gap between their positive attitudes towards PGx and the practical knowledge and systemic support required for clinical implementation. The findings revealed that the identified deficits in knowledge and readiness were widespread across all surveyed subgroups, not concentrated in specific demographic or professional subgroups. Translating the existing positive sentiment into routine clinical practice urgently requires a nationwide, standardized educational strategy coupled with the development of systemic enablers, including reimbursement pathways, integrated clinical workflows, and explicit leadership support.
- Open Access
- 13 April 2026
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 19 (1)
Digital health literacy as a predictor of patient safety culture: evidence from a multi-centre study of Jordanian nurses
The digitalisation of healthcare requires nurses to possess strong Digital Health Literacy (DHL) to ensure patient safety. This study aimed to evaluate the relationship between DHL and perceptions of PSC among registered nurses in Jordan and to identify the demographic and professional factors associated with varying levels of DHL. A multi-center, cross-sectional survey was conducted from July to September 2025 across five public, private, and university-affiliated hospitals in Jordan. A sample of 500 registered nurses was recruited using stratified random sampling. Data were collected using a validated, seven-part composite questionnaire. Data were analyzed using descriptive statistics, reliability analysis (Cronbach’s alpha), and structural equation modelling. The results confirmed the study's primary hypothesis, revealing a significant and strong positive predictive relationship between DHL and PSC (β = 0.42, p < 0.001), with DHL explaining 28.1% of the variance in PSC. Nurses reported moderately high DHL overall (M = 3.28), with strengths in operational skills but lower confidence in evaluating information reliability. Perceptions of patient safety culture were positive (M = 3.71), with Teamwork Climate rated highest (M = 4.21) and Perceptions of Management lowest (M = 3.34). Significant disparities in DHL were found; higher levels of education (p < .001) and working in a university-affiliated hospital (p = 0.001) were associated with higher competency. Notably, no significant differences were observed based on age or years of experience. Lack of adequate training and insufficient time were identified as the primary organisational barriers to technology use. Digital health literacy was significantly associated with better patient safety culture among Jordanian nurses, driven more by organisational and educational factors than generational stereotypes. To realise the safety benefits of digital health investments, institutions should strengthen nurses’ digital and critical appraisal skills and remove organisational barriers.
- 13 April 2026
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 19 (1)
Open AccessDigital health literacy as a predictor of patient safety culture: evidence from a multi-centre study of Jordanian nurses
The digitalisation of healthcare requires nurses to possess strong Digital Health Literacy (DHL) to ensure patient safety. This study aimed to evaluate the relationship between DHL and perceptions of PSC among registered nurses in Jordan and to identify the demographic and professional factors associated with varying levels of DHL. A multi-center, cross-sectional survey was conducted from July to September 2025 across five public, private, and university-affiliated hospitals in Jordan. A sample of 500 registered nurses was recruited using stratified random sampling. Data were collected using a validated, seven-part composite questionnaire. Data were analyzed using descriptive statistics, reliability analysis (Cronbach’s alpha), and structural equation modelling. The results confirmed the study's primary hypothesis, revealing a significant and strong positive predictive relationship between DHL and PSC (β = 0.42, p < 0.001), with DHL explaining 28.1% of the variance in PSC. Nurses reported moderately high DHL overall (M = 3.28), with strengths in operational skills but lower confidence in evaluating information reliability. Perceptions of patient safety culture were positive (M = 3.71), with Teamwork Climate rated highest (M = 4.21) and Perceptions of Management lowest (M = 3.34). Significant disparities in DHL were found; higher levels of education (p < .001) and working in a university-affiliated hospital (p = 0.001) were associated with higher competency. Notably, no significant differences were observed based on age or years of experience. Lack of adequate training and insufficient time were identified as the primary organisational barriers to technology use. Digital health literacy was significantly associated with better patient safety culture among Jordanian nurses, driven more by organisational and educational factors than generational stereotypes. To realise the safety benefits of digital health investments, institutions should strengthen nurses’ digital and critical appraisal skills and remove organisational barriers.
- Open Access
- 24 March 2026
- Published by Oxford University Press (OUP) in International Journal of Pharmacy Practice
- Vol. 34 (5) , 615-624
Community pharmacists’ perceptions and practices regarding medication home delivery service: a cross-sectional study in the United Arab Emirates
Objectives: The healthcare sector is evolving with a growing emphasis on remote services and patient-centred care. Medication Home Delivery (MHD) service has become essential in enhancing accessibility, allowing patients to receive medications at home. This study evaluates the perceptions, practices, challenges, and benefits of the MHD service among community pharmacists in the United Arab Emirates (UAE), providing insights for policy and practice improvements. Methods: A cross-sectional survey was conducted among 403 licensed community pharmacists in the UAE. Participants completed a self-administered questionnaire assessing their awareness, perceptions, and experiences with the MHD service. Data analysis included descriptive statistics and logistic regression to identify factors influencing service provision. Key findings: Among respondents, 83.6% offered the MHD service, primarily through online platforms. Main factors influencing service provision included participants’ age, employment status, pharmacy type, and location (P < .05). Pharmacists raised concerns about patient counseling quality, communication, and medication security, highlighting the need for training to improve regulatory adherence. Major challenges included staffing shortages (51.6%), increased workload (36.5%), and limited time for patient counseling (41.2%). Despite these barriers, most pharmacists recognized MHD’s benefits in enhancing pharmacy efficiency (87.2%) and patient convenience (51.3%), particularly for elderly and disabled individuals (86.9%). Those not offering the MHD service cited unclear policies (24.2%) and logistical constraints as primary barriers (24.2%). Conclusions: This study underscores both the opportunities and operational challenges of the MHD service in the UAE community pharmacies. Optimizing the service requires policy refinements, improved logistical frameworks, and targeted training programs to enhance service delivery, regulatory compliance, and patient care outcomes.
- 24 March 2026
- Published by Oxford University Press (OUP) in International Journal of Pharmacy Practice
- Vol. 34 (5) , 615-624
Open AccessCommunity pharmacists’ perceptions and practices regarding medication home delivery service: a cross-sectional study in the United Arab Emirates
Objectives: The healthcare sector is evolving with a growing emphasis on remote services and patient-centred care. Medication Home Delivery (MHD) service has become essential in enhancing accessibility, allowing patients to receive medications at home. This study evaluates the perceptions, practices, challenges, and benefits of the MHD service among community pharmacists in the United Arab Emirates (UAE), providing insights for policy and practice improvements. Methods: A cross-sectional survey was conducted among 403 licensed community pharmacists in the UAE. Participants completed a self-administered questionnaire assessing their awareness, perceptions, and experiences with the MHD service. Data analysis included descriptive statistics and logistic regression to identify factors influencing service provision. Key findings: Among respondents, 83.6% offered the MHD service, primarily through online platforms. Main factors influencing service provision included participants’ age, employment status, pharmacy type, and location (P < .05). Pharmacists raised concerns about patient counseling quality, communication, and medication security, highlighting the need for training to improve regulatory adherence. Major challenges included staffing shortages (51.6%), increased workload (36.5%), and limited time for patient counseling (41.2%). Despite these barriers, most pharmacists recognized MHD’s benefits in enhancing pharmacy efficiency (87.2%) and patient convenience (51.3%), particularly for elderly and disabled individuals (86.9%). Those not offering the MHD service cited unclear policies (24.2%) and logistical constraints as primary barriers (24.2%). Conclusions: This study underscores both the opportunities and operational challenges of the MHD service in the UAE community pharmacies. Optimizing the service requires policy refinements, improved logistical frameworks, and targeted training programs to enhance service delivery, regulatory compliance, and patient care outcomes.
- Open Access
- 2 March 2026
- Published by Springer Nature in BMC Medical Education
- Vol. 26 (1)
Assessing Knowledge, Attitudes, and Practices (KAP) related to green pharmacy among community and hospital pharmacists in Jordan
Background: Pharmaceutical pollution is a growing global concern with serious implications for ecosystems, human health, and water quality. In Jordan, this issue is amplified by weak enforcement of disposal regulations and low public awareness, with studies showing as few as 10% of residents return unused medicines to pharmacies. As trusted medication experts, pharmacists are uniquely positioned to advocate for and implement green pharmacy practices, the integration of environmental stewardship across the pharmaceutical lifecycle. However, the extent to which Jordanian pharmacists are equipped and enabled to fulfill this role has not been systematically assessed. Objective: This study aimed to provide the first comprehensive assessment of the knowledge, attitudes, and practices (KAP) of both hospital and community pharmacists in Jordan regarding green pharmacy and to identify key predictors of their engagement. Methods: This cross-sectional survey was conducted over a one-month period among 380 licensed pharmacists practicing in community and hospital settings across Jordan’s three administrative regions. A validated, self-administered questionnaire was used to assess KAP, perceived barriers, and recommendations. The primary outcomes were scores for knowledge, attitudes, and practices. Descriptive statistics were used to summarize KAP levels, and three separate multivariable logistic regression models were developed to identify predictors of Good Knowledge (score ≥ 80%), Positive Attitude (score > 27), and Good Practice (score ≥ 23). Results: The study identified a significant attitude-practice gap. While pharmacists demonstrated overwhelmingly positive attitudes (mean score 4.4 ± 0.7), this did not translate into consistent practice (mean score 2.9 ± 1.2), particularly for actions requiring systemic support. Multivariable logistic regression analyses revealed that prior training was a consistent and powerful predictor across all domains. Good Knowledge (score ≥ 80%) was most strongly predicted by prior training (aOR = 5.21) and practicing in a chain pharmacy (aOR = 1.60). Highly Positive Attitude (mean score > 4.0) was significantly predicted by younger age (< 35 years; aOR = 1.95) and prior training (aOR = 1.80). Critically, Good Practice (mean score ≥ 3.5) was not predicted by attitude, but by structural and educational factors: prior training (aOR = 3.85), practicing in a chain pharmacy (aOR = 2.01), and a hospital setting (aOR = 1.75). Conclusion: This study, the first to assess comprehensively KAP on this topic in Jordan, underscored that the primary barriers to green pharmacy were systemic, not a lack of professional will. The findings provided an evidence-based roadmap, highlighting the urgent need for national guidelines, targeted training, and supportive infrastructure to empower pharmacists to translate their positive attitudes into meaningful environmental stewardship.
- 2 March 2026
- Published by Springer Nature in BMC Medical Education
- Vol. 26 (1)
Open AccessAssessing Knowledge, Attitudes, and Practices (KAP) related to green pharmacy among community and hospital pharmacists in Jordan
Background: Pharmaceutical pollution is a growing global concern with serious implications for ecosystems, human health, and water quality. In Jordan, this issue is amplified by weak enforcement of disposal regulations and low public awareness, with studies showing as few as 10% of residents return unused medicines to pharmacies. As trusted medication experts, pharmacists are uniquely positioned to advocate for and implement green pharmacy practices, the integration of environmental stewardship across the pharmaceutical lifecycle. However, the extent to which Jordanian pharmacists are equipped and enabled to fulfill this role has not been systematically assessed. Objective: This study aimed to provide the first comprehensive assessment of the knowledge, attitudes, and practices (KAP) of both hospital and community pharmacists in Jordan regarding green pharmacy and to identify key predictors of their engagement. Methods: This cross-sectional survey was conducted over a one-month period among 380 licensed pharmacists practicing in community and hospital settings across Jordan’s three administrative regions. A validated, self-administered questionnaire was used to assess KAP, perceived barriers, and recommendations. The primary outcomes were scores for knowledge, attitudes, and practices. Descriptive statistics were used to summarize KAP levels, and three separate multivariable logistic regression models were developed to identify predictors of Good Knowledge (score ≥ 80%), Positive Attitude (score > 27), and Good Practice (score ≥ 23). Results: The study identified a significant attitude-practice gap. While pharmacists demonstrated overwhelmingly positive attitudes (mean score 4.4 ± 0.7), this did not translate into consistent practice (mean score 2.9 ± 1.2), particularly for actions requiring systemic support. Multivariable logistic regression analyses revealed that prior training was a consistent and powerful predictor across all domains. Good Knowledge (score ≥ 80%) was most strongly predicted by prior training (aOR = 5.21) and practicing in a chain pharmacy (aOR = 1.60). Highly Positive Attitude (mean score > 4.0) was significantly predicted by younger age (< 35 years; aOR = 1.95) and prior training (aOR = 1.80). Critically, Good Practice (mean score ≥ 3.5) was not predicted by attitude, but by structural and educational factors: prior training (aOR = 3.85), practicing in a chain pharmacy (aOR = 2.01), and a hospital setting (aOR = 1.75). Conclusion: This study, the first to assess comprehensively KAP on this topic in Jordan, underscored that the primary barriers to green pharmacy were systemic, not a lack of professional will. The findings provided an evidence-based roadmap, highlighting the urgent need for national guidelines, targeted training, and supportive infrastructure to empower pharmacists to translate their positive attitudes into meaningful environmental stewardship.
- Open Access
- 30 December 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
The impact of artificial intelligence on the prescribing, selection, resistance, and stewardship of antimicrobials: a scoping review
Antimicrobial selection, prescribing, and resistance are global health issues resulting from the overuse and misuse of antimicrobials in the healthcare and
- 30 December 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessThe impact of artificial intelligence on the prescribing, selection, resistance, and stewardship of antimicrobials: a scoping review
Antimicrobial selection, prescribing, and resistance are global health issues resulting from the overuse and misuse of antimicrobials in the healthcare and
- Open Access
- 23 December 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (12) , e0339327
Assessing community pharmacists’ responses to pregnancy-related nausea and vomiting: A national simulated patient study in Jordan
Background and aim: Nausea and vomiting of pregnancy (NVP) is the most common medical condition of gestation, affecting up to 90% of women and significantly impacting their quality of life. Community pharmacists (CPs) are often the first point of contact for these women, yet there is a lack of objective data on their practice quality in Jordan. This study aimed to conduct the first national, simulated patient study to assess objectively the assessment, management, counseling, satisfaction and predictors of appropriate practice among Jordanian community CPs when managing NVP. Materials and methods: A national, cross-sectional study using a simulated patient methodology was conducted in 380 community pharmacies, selected via proportionate stratified random sampling. Two validated scenarios (mild NVP and severe NVP with red flags) were used. A validated structured data collection form documented CPs ‘ assessment, management, counseling, and patient satisfaction. Multivariable logistic regression was used to identify independent predictors of “Appropriate Practice.” All data were analysed using SPSS (V28.0). Results: A significant gap between guideline-recommended care and actual practice was evident, particularly in high-risk situations. While most CPs (84.2%) initiated symptom inquiry, crucial assessment of red flags in the severe NVP scenario was dangerously low (e.g., inquiry about dehydration, 21.1%). This assessment failure translated directly to practice: only 56.8% of CPs correctly referred the high-risk patient, while 43.2% inappropriately sold an over-the-counter medication, delaying necessary medical care. Counseling on medication safety was consistently poor, with only 29.9% of CPs discussing potential side effects. Despite these clinical deficiencies, the overall patient satisfaction was high, appearing to be driven more by interpersonal skills than clinical accuracy. Multivariable analysis revealed that appropriate practice was independently predicted by prior maternal health training (aOR = 3.48, p < 0.001) and being a female pharmacist (aOR = 2.01, p = 0.009). Conversely, a high pharmacy workload was a significant independent barrier, reducing the odds of providing appropriate care by 50% (aOR = 0.50, p = 0.018). Conclusion: Jordanian community CPs are a critical but currently underperforming resource in maternal care. The prevalent gaps in clinical assessment and referral for severe NVP represent a significant patient safety risk. A one-size-fits-all approach to quality improvement is unlikely to succeed. Instead, a dual-pronged strategy is essential: (1) national professional pharmacy bodies must mandate targeted continuing professional development in maternal health, focusing on risk assessment and referral protocols; and (2) health policymakers and community pharmacy owners must address systemic barriers, particularly the detrimental impact of high workload on the delivery of safe and effective patient care.
- 23 December 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (12) , e0339327
Open AccessAssessing community pharmacists’ responses to pregnancy-related nausea and vomiting: A national simulated patient study in Jordan
Background and aim: Nausea and vomiting of pregnancy (NVP) is the most common medical condition of gestation, affecting up to 90% of women and significantly impacting their quality of life. Community pharmacists (CPs) are often the first point of contact for these women, yet there is a lack of objective data on their practice quality in Jordan. This study aimed to conduct the first national, simulated patient study to assess objectively the assessment, management, counseling, satisfaction and predictors of appropriate practice among Jordanian community CPs when managing NVP. Materials and methods: A national, cross-sectional study using a simulated patient methodology was conducted in 380 community pharmacies, selected via proportionate stratified random sampling. Two validated scenarios (mild NVP and severe NVP with red flags) were used. A validated structured data collection form documented CPs ‘ assessment, management, counseling, and patient satisfaction. Multivariable logistic regression was used to identify independent predictors of “Appropriate Practice.” All data were analysed using SPSS (V28.0). Results: A significant gap between guideline-recommended care and actual practice was evident, particularly in high-risk situations. While most CPs (84.2%) initiated symptom inquiry, crucial assessment of red flags in the severe NVP scenario was dangerously low (e.g., inquiry about dehydration, 21.1%). This assessment failure translated directly to practice: only 56.8% of CPs correctly referred the high-risk patient, while 43.2% inappropriately sold an over-the-counter medication, delaying necessary medical care. Counseling on medication safety was consistently poor, with only 29.9% of CPs discussing potential side effects. Despite these clinical deficiencies, the overall patient satisfaction was high, appearing to be driven more by interpersonal skills than clinical accuracy. Multivariable analysis revealed that appropriate practice was independently predicted by prior maternal health training (aOR = 3.48, p < 0.001) and being a female pharmacist (aOR = 2.01, p = 0.009). Conversely, a high pharmacy workload was a significant independent barrier, reducing the odds of providing appropriate care by 50% (aOR = 0.50, p = 0.018). Conclusion: Jordanian community CPs are a critical but currently underperforming resource in maternal care. The prevalent gaps in clinical assessment and referral for severe NVP represent a significant patient safety risk. A one-size-fits-all approach to quality improvement is unlikely to succeed. Instead, a dual-pronged strategy is essential: (1) national professional pharmacy bodies must mandate targeted continuing professional development in maternal health, focusing on risk assessment and referral protocols; and (2) health policymakers and community pharmacy owners must address systemic barriers, particularly the detrimental impact of high workload on the delivery of safe and effective patient care.